About Calidi Biotherapeutics
Calidi Biotherapeutics is a private company based in San Diego, California. It has reported $4,999,975 raised in one offering on Form D since June 2023. Its chief executive is Allan Camaisa.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 20, 2023 | Jun 29, 2023 | $4,999,975of $25.0M target | 1 | $4.9M | Equity, Securities on exercise, Series B Preferred Stock and Common StockRule 506(c) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Calidi Biotherapeutics's Form D filed Jun 29, 2023.
AC
Allan Camaisa
CEO and director
HL
Heehyoung Lee
Director
JS
James Schoeneck
Director
AZ
Alfonso Zulueta
Director
AS
Anthony Santidrian
Executive officer
BM
Boris Minev
Interim Chief Medical Officer
ST
Stephen Thesing
Chief Business Officer
TK
Tony Kalajian
Interim Chief Financial Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director
GN